Fig. 3

Flow diagram of treatment evolution in the two study groups. Persistent patients continued on their migraine preventive medication during the 12-month follow-up period or switched to another line of treatment within 60 days from the last prescription. Non-persistent patients permanently discontinued their preventive treatment or restarted it after 60 days